Envoy Medical, Inc.
NasdaqCM COCH
Envoy Medical, Inc. Revenue Per Share for the Trailing 12 Months (TTM) ending September 30, 2024: USD 0.01
Envoy Medical, Inc. Revenue Per Share is USD 0.01 for the Trailing 12 Months (TTM) ending September 30, 2024, a 98.21% change year over year. Revenue per share indicates revenue generated per share; higher ratios suggest stronger performance and value.
-
Envoy Medical, Inc. Revenue Per Share for the Trailing 12 Months (TTM) ending September 30, 2023 was USD 0.01, a 4.41% change year over year.
-
Envoy Medical, Inc. Revenue Per Share for the Trailing 12 Months (TTM) ending September 30, 2022 was USD 0.01.
Key data
| Date | Revenue Per Share | Dividend Per Share | Free Cash Flow Per Share | Return on Assets (ROA) |
|---|
Market news
Loading...
NasdaqCM: COCH
| CEO | Mr. Brent T. Lucas Esq. |
| IPO Date | April 29, 2021 |
| Location | United States |
| Headquarters | 4875 White Bear Parkway |
| Employees | 34 |
| Sector | Health Care |
| Industries | |
Description
Envoy Medical, Inc., a hearing health company, provides medical technologies for the hearing loss spectrum. Its products include hearing aids; Esteem middle ear implants; bone conduction devices; and Acclaim cochlear implants. Envoy Medical Corporation was formerly known as St. Croix Medical, Inc. and changed its name to Envoy Medical Corporation in December 2004. The company was founded in 1995 and is based in White Bear Lake, Minnesota.
Key trends
Past 5 years
StockViz Staff
January 15, 2025
Any question? Send us an email